Interestingly, we also saw different behaviors of KIR3DL1 expression in myeloid and lymphoid leukemias, but there was no leukemic blast infiltration during the first three months, suggesting the influence of pre-transplant treatment, rather than the type of leukemia. The gene discussed is KIR3DL1; the disease is leukemia.